Log in to your Inderes Free account to see all free content on this page.
Xvivo Perfusion
466.5
SEK
+1.08 %
XVIVO
NASDAQ Stockholm
Medical Equipment & Services
Health Care
5 following
+1.08%
+3.21%
-9.24%
+10.15%
+41.58%
+52.2%
+86.23%
+175.38%
+2,355.26%
Xvivo Perfusion is a medical technology company. The company provides solutions for lung transplantation. Examples of products that the company delivers include needles, organ storage, and cooling solutions. The products are resold to clinics and research institutes around the global market, with the largest business presence in the Nordics and Europe. The company was established via a spin-off from Vitrolife in 2012 and is headquartered in Gothenburg.
Read moreMarket cap
14.69B SEK
Turnover
22.14M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
28.1.
2025
Annual report '24
24.4.
2025
Interim report Q1'25
25.4.
2025
General meeting '24
ShowingAll content types
XVIVO Perfusion appoints Lena Hagman as deputy CEO
Redeye: XVIVO Update - Excellent organic growth and a negative currency surprise
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio